State AGs urge Pennsylvania court to select dermatology lawsuit as bellwether
A Connecticut-led group of states has argued that its lawsuit alleging collusion in markets for dermatological products should be the first to go to trial in sprawling multidistrict litigation accusing generic drug manufacturers of price-fixing and market allocation.
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10